ghk-cu wound healing clinical study human In Vitro and in Vivo Studies of pH-Sensitive GHK-Cu-Incorporated Polyaspartic and Polyacrylic Acid Superabsorbent Polymer GHK-Cu Dosing: 1.7mg/Day Injectable (2026)
Description
2012 Dec;40(12):2720-4
Resulting in an even skin tone
It is a research compound, not an approved drug or an over-the-counter bodybuilding supplement
Competitive radioligand binding assays reveal concentration-dependent displacement curves, indicating specific receptor engagement at nanomolar concentrations
